Page last updated: 2024-10-27

fluconazole and Tuberculosis, Pulmonary

fluconazole has been researched along with Tuberculosis, Pulmonary in 14 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.

Research Excerpts

ExcerptRelevanceReference
" She was then diagnosed as disseminated cryptococcosis and treated with liposomal amphotericin B and fluconazole successfully."3.83[A pediatric case of HIV who diagnosed by virtue of disseminated cryptococcus infection]. ( Acar, M; Ağaçfidan, A; Aktürk, H; Beka, H; Hançerli Törün, S; Karagöz, N; Salman, N; Somer, A; Sütçü, M; Yekeler, E, 2016)
"Neuromeningeal cryptococcosis and pulmonary tuberculosis are respectively serious mycotic and bacterial infections occurring in a subject regardless of its HIV serological status."1.72[Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali]. ( Alle Akakpo, AE; Cissoko, Y; Dao, S; Konaté, I; Loua, OO; Ouedraogo, D; Soumaré, M, 2022)
"Fluconazole was administered and the computed tomography findings improved."1.56Pulmonary Cryptococcosis in a Nurse Initially Suspected of Having Pulmonary Tuberculosis. ( Ikeda, H; Kasai, H; Ogawa, H; Shinozaki, T; Urushibara, T, 2020)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's4 (28.57)18.2507
2000's4 (28.57)29.6817
2010's1 (7.14)24.3611
2020's4 (28.57)2.80

Authors

AuthorsStudies
Loua, OO1
Alle Akakpo, AE1
Ouedraogo, D1
Cissoko, Y1
Soumaré, M1
Konaté, I1
Dao, S1
Monzani, V1
Córdoba, S1
Vivot, M1
Arias, B1
Vivot, W1
Szusz, W1
Castellaro, P1
Appendino, A1
Taverna, CG1
Ogawa, H1
Urushibara, T1
Kasai, H1
Ikeda, H1
Shinozaki, T1
Johnson, K1
Dhamrah, U1
Amin, A1
Masci, J1
Acar, M1
Sütçü, M1
Aktürk, H1
Hançerli Törün, S1
Karagöz, N1
Beka, H1
Yekeler, E1
Ağaçfidan, A1
Salman, N1
Somer, A1
Bereznikov, AV1
Mordyk, AV1
Lysov, AV1
Konev, VP1
Kingkaew, N1
Sangtong, B1
Amnuaiphon, W1
Jongpaibulpatana, J1
Mankatittham, W1
Akksilp, S1
Sirinak, C1
Nateniyom, S1
Burapat, C1
Kittikraisak, W1
Monkongdee, P1
Varma, JK1
Nuevo, JA1
Hijano, A1
Eimil, M1
Valdivia, A1
Candel, FJ1
Núñez, MJ1
Roca, V1
MESCOLINI, G1
Kul'ko, AB1
Mitrokhin, SD1
Moroz, AM1
Onizuka, O2
Kawano, M1
Takikawa, S1
Sugihara, R1
Ando, H1
Peloquin, CA1
Nitta, AT1
Burman, WJ1
Brudney, KF1
Miranda-Massari, JR1
McGuinness, ME1
Berning, SE1
Gerena, GT1
Bani-Sadr, F1
Hoff, J1
Chiffoleau, A1
Allavena, C1
Raffi, F1
Yoshimatsu, T1
Matsumoto, T1
Tsuda, T1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
DNA Sequencing of MDR TB in Eastern Siberia[NCT02508610]630 participants (Anticipated)Observational2013-11-30Recruiting
A Phase II Trial to Describe the Pharmacokinetics, Safety and Efficacy of Pharmacogenetics-guided Dosing of Isoniazid in Patients With HIV-associated TB[NCT05124678]Phase 240 participants (Anticipated)Interventional2021-12-07Recruiting
A Randomized, Four-arm Open Label Phase Two-b Clinical Trial to Evaluate the Pharmacokinetics, Safety/Tolerability and Efficacy of High Dose Rifampicin in TB-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy[NCT03982277]Phase 2130 participants (Actual)Interventional2019-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for fluconazole and Tuberculosis, Pulmonary

ArticleYear
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996
Low antituberculosis drug concentrations in patients with AIDS.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Flucona

1996

Other Studies

13 other studies available for fluconazole and Tuberculosis, Pulmonary

ArticleYear
[Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali].
    Medecine tropicale et sante internationale, 2022, 12-31, Volume: 2, Issue:4

    Topics: Acetaminophen; Adolescent; AIDS-Related Opportunistic Infections; Communicable Diseases; Cryptococco

2022
A case report of catheter-related bloodstream infection due to Trichosporon coremiiforme in a patient with secondary neutropenia to HIV.
    Journal de mycologie medicale, 2020, Volume: 30, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Bacteremia; Catheter-R

2020
Pulmonary Cryptococcosis in a Nurse Initially Suspected of Having Pulmonary Tuberculosis.
    The American journal of case reports, 2020, Jan-11, Volume: 21

    Topics: Adult; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cryptococcosis; Delayed Diagnosis; Female; Flucon

2020
Case Report: A Great Mimicker of Neoplasm: Pulmonary Cryptococcosis in an Immunocompetent Host After High-Altitude Descent.
    The American journal of tropical medicine and hygiene, 2021, 06-14, Volume: 105, Issue:2

    Topics: Aged, 80 and over; Altitude; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis,

2021
[A pediatric case of HIV who diagnosed by virtue of disseminated cryptococcus infection].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Ch

2016
[Antibiotic-associated diarrheas in phthisiatric care: standardization of their diagnosis, treatment, prevention, examination of health care quality].
    Problemy tuberkuleza i boleznei legkikh, 2008, Issue:7

    Topics: Anti-Bacterial Agents; Antidiarrheals; Antifungal Agents; Diarrhea; Fluconazole; Follow-Up Studies;

2008
HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2009, Volume: 13, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Cohort Studies

2009
[Candida esophagitis in a non-immunosuppressed patient].
    Revista espanola de enfermedades digestivas, 2002, Volume: 94, Issue:8

    Topics: Adult; Antifungal Agents; Antitubercular Agents; Candidiasis; Esophagitis; Female; Fluconazole; Huma

2002
[Topography and morphology of zonal pulmonary densities caused by tuberculous primary infection (forms with favorable evolution); clinico-pathogenetic and therapeutic considerations].
    Omnia therapeutica. Supplemento, 1957, Volume: 34

    Topics: Fluconazole; Humans; Lung; Radiography; Tuberculosis; Tuberculosis, Pulmonary

1957
[Respiratory tract mycotic infection in phthisiological practice: species composition and susceptibility of the Candida clinical isolates to antifungal agents].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itrac

2005
[Pharmacokinetics of transbronchially injected flconazole in pulmonary aspergillosis].
    Nihon Kyobu Shikkan Gakkai zasshi, 1995, Volume: 33, Issue:2

    Topics: Aged; Aspergillosis; Bronchi; Epithelium; Female; Fluconazole; Humans; Injections, Intralesional; Lu

1995
[Severe hypercalcemia in a patient treated with fluconazole and rifampicin].
    Presse medicale (Paris, France : 1983), 1998, May-16, Volume: 27, Issue:18

    Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antifungal Agents; Female

1998
[Percutaneous instillation of fluconazole in the treatment of pulmonary aspergilloma].
    Nihon Kyobu Shikkan Gakkai zasshi, 1991, Volume: 29, Issue:10

    Topics: Administration, Cutaneous; Aged; Aspergillosis; Female; Fluconazole; Humans; Injections, Intralesion

1991